FDA panel votes not to support Eisai, Astex cancer drug
FDA Oncologic Drugs Advisory Committee votes against risk-benefit profile for Dacogen in some leukemia patients
An expert panel at the Food and Drug Administration has given a thumbs-down to a drug made by Astex Pharmaceuticals and Eisai for which the two had sought approval as a treatment for leukemia.
Post a Comment
Footer Content
Retail Group
Events - Retail
Industry Guides, Research & Reports
International
footer
© 2012 Drug Store News. All Rights Reserved.